$61.39
−2.63%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$63.37
From 52W high−4.59%
Volume2.59M
Market cap$9.35B
P/E (TTM)—
P/S (TTM)2.7x
Div yield0.33%
Key dataSep 18, 2026
Open
$63.37
From 52W high
−4.59%
Volume
2.59M
Market cap
$9.35B
ValuationView details →
P/E (Fwd)
27.1x
EV/EBITDA
44.8x
P/E (TTM)
—
RSI (14)
56.8
MomentumView details →
1D Return
−2.63%
YTD Return
+29.46%
SummaryUpdated Jun 1, 2026
Bruker Corporation (NASDAQ:BRKR) is a leading developer, manufacturer, and distributor of scientific instruments and analytical solutions founded in 1991 and headquartered in Billerica, Massachusetts. The company went public in 2000 and has grown through strategic acquisitions and organic expansion to become a major player in the life sciences, materials research, and industrial analysis markets. Bruker serves customers globally across academic research institutions, pharmaceutical companies, biotechnology firms, government laboratories, and industrial manufacturers with sophisticated analytical instruments that enable scientific discovery and quality control processes.
Similar companies
Latest newsMore news →
Bank of America Corp DE reduced its stake in Bruker Corporation by 3.2% during the quarter, selling 30,371 shares, according to a Form 13F filing.36d agoBruker Corp reported Q2 2026 total revenue of $838.5 million, a 5.2% increase year-over-year, with a GAAP diluted loss per share of $0.41 and non-GAAP diluted EPS of $0.49, and provided FY2026 guidance for organic revenue growth of 1-2% and non-GAAP EPS of $2.10-$2.15.48d ago